Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases

J Eur Acad Dermatol Venereol. 2017 May;31(5):e245-e246. doi: 10.1111/jdv.14034. Epub 2016 Nov 20.

Authors

M González-Medina¹, L Curto-Barredo², M Labrador-Horrillo¹, A Giménez-Arnau²

Affiliations

¹ Allergy Section, Vall d'Hebron Hospital, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
² Dermatology Department, Hospital del Mar, Universitat Autònoma de Barcelona, Passeig Marítim, 25-29, 08003, Barcelona, Spain.

PMID: 27868240
DOI: 10.1111/jdv.14034

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Allergic Agents / therapeutic use
Chronic Disease
Female
Humans
Omalizumab / therapeutic use*
Pregnancy
Pregnancy Complications / drug therapy*
Urticaria / drug therapy*

Substances

Anti-Allergic Agents
Omalizumab